Template:Drug List/ja: Difference between revisions
No edit summary |
No edit summary |
||
| Line 51: | Line 51: | ||
| list6 = | | list6 = | ||
{{Navbox|subgroup | {{Navbox|subgroup | ||
|group1=[[Diabetes medication/ja|糖尿病治療薬]] | |group1=[[Diabetes medication/ja|糖尿病治療薬]] | ||
|list1= | |list1={{Navbox|child | ||
|group1=[[Insulin/ja|インスリン]]/[[insulin analog/ja|インスリンアナログ]] | |||
|list1= | |||
* 超速効型 | |||
** [[Insulin aspart/ja]] | |||
** [[Insulin lispro/ja]] | |||
** [[Insulin glulisine/ja]] | |||
* 速効型 | |||
** [[Regular insulin/ja]] | |||
* 中間型 | |||
** [[NPH insulin/ja]] | |||
* 持効型 | |||
** [[Insulin degludec/ja]] | |||
** [[Insulin detemir/ja]] | |||
** [[Insulin glargine/ja]] | |||
|group2=非インスリン | |||
|list2={{Navbox|child | |||
|group1=[[Anti-diabetic medication#Sensitizers/ja|インスリン感作薬]] | |||
|list1= | |||
* [[Biguanide/ja]] | |||
* [[Thiazolidinedione/ja|TZD]]/"グリタゾン" ([[PPAR agonist/ja|PPAR]]) | |||
* [[PPAR agonist/ja#Dual PPAR agonists|デュアルPPAR作動薬]] | |||
* [[Amylin/ja]]アナログと[[DACRA/ja|DACRA]] | |||
|group2=[[Anti-diabetic medication/ja#Secretagogues|セクレタゴーグ]] | |||
|list2= | |||
* [[ATP-sensitive potassium channel/ja|K<sup>+</sup><sub>ATP</sub>]] | |||
** [[Sulfonylurea/ja]] | |||
** [[Meglitinide/ja]]/"グリニド系" | |||
* [[Gliflozin/ja|SGLT2 阻害薬]]/"グリフロジン" | |||
* [[Glucagon-like peptide-1 receptor agonist/ja|GLP-1受容体作動薬]] | |||
* [[Dipeptidyl peptidase-4 inhibitor/ja|DPP-4 阻害薬]]/"グリプチン" | |||
* [[Aldose reductase inhibitor/ja]] | |||
* [[Alpha-glucosidase inhibitor/ja]] | |||
* その他 | |||
** [[Benfluorex/ja]]<sup>‡</sup> | |||
** [[Bromocriptine/ja]] | |||
** [[Imeglimin/ja]] | |||
|group3=配合薬 | |||
|list3=配合薬 | |||
}} | |||
}} | |||
}} | }} | ||
<!-------------------------------------> | <!-------------------------------------> | ||